How about insulin and Diabetes and the below information from our CEO:
"Meetings have been held between Nuvilex's principal officers and scientists and principals from some of the major universities in Europe concerning the use of the Cell-in-a-Box® technology in developing a treatment for insulin-dependent diabetes. Scientists at one of these institutions have developed unique transgenic animal models for insulin-dependent diabetes. Nuvilex has initiated negotiations for their use in its studies of this disease. In addition, scientists at an Australian university have developed a human cell line that secretes increasing amounts of insulin in response to increasing levels of glucose in their surroundings. If the results of preclinical tests on these cells are positive, Nuvilex will finalize negotiations to acquire this cell line for use with Cell-in-a-Box(R) technology as a first step in developing its treatment for diabetes."
AND
"As for diabetes, an area of great excitement for Nuvilex, meetings were held with a representative of the university from which Nuvilex plans to license the human insulin-producing cell line that will be used to develop a treatment for insulin-dependent diabetes. Importantly, a separate meeting was held with a representative of the Juvenile Diabetes Research Foundation which is based in the US. Additional meetings are being planned with the JDRF in the near future to explore ways the company and the Foundation may collaborate."
When reading through the posts after work very early this morning the post that stood out to me most was THIS POST. Piie Two this post is outstanding. CiaB is more than delivering drugs. It's a delivery for a multitude of things. It can go places in the body no man has gone before.
News 
Market Data 
Discover 
